Trial Profile
Phase III trial of JDP 205 intravenous injection for the treatment of urticaria associated with an allergic reaction
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2015
Price :
$35
*
At a glance
- Drugs Cetirizine (Primary)
- Indications Hypersensitivity; Urticaria
- Focus Registrational; Therapeutic Use
- 08 Jan 2015 The initial phase III trial has been completed and JDP Therapeutics is working with the US FDA on the design of this larger phase III trial, according to a company media release.
- 03 Feb 2014 New trial record